The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
PREVENTION OF PNEUMOCOCCAL PNEUMONIA BY IMMUNIZATION WITH SPECIFIC CAPSULAR POLYSACCHARIDES
Open accessAbstract
1. Immunization of man with 0.03 to 0.06 mg. of each of the capsular polysaccharides of pneumococcus types I, II, V, and VII, given in a single subcutaneous injection, has been shown to be effective in preventing pneumonia caused by these types but not that due to heterologous types. 2. Immunity appears within a period of 2 weeks following injection of the polysaccharides. Its duration was not determined, although 6 months can be set as a minimum. 3. Immunization of alternate subjects in the population reduced greatly the incidence of pneumonia in the non-immunized. 4. The carrier rate for pneumococcus types I, II, V, and VII was lowered significantly in the immunized group as compared with the controls. It is suggested that an over-all reduction in the incidence of carriers was responsible for the lowered rates for pneumococcal pneumonia in the non-immunized group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pneumonia, With Special Reference To Pneumococcus Lobar Pneumonia
(1940) · American Journal of Clinical Pathology · doi:10.1093/ajcp/10.5.356 · Cited by 181
Cited by
Hao (2015) · doi:10.1002/14651858 · Cited by 11,321
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Bacterial Meningitis in the United States in 1995
Schuchat, A., Robinson, K., Wenger, J. D., Harrison, L. H., Farley, M., Reingold, A. L., Lefkowitz, L., & Perkins, B. A. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710023371404 · Cited by 1,251
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub3 · Cited by 960
Pneumococcal Bacteremia with Especial Reference to Bacteremic Pneumococcal Pneumonia
AUSTRIAN, R., & GOLD, J. (1964) · Annals of Internal Medicine · doi:10.7326/0003-4819-60-5-759 · Cited by 923
Epidemiological differences among pneumococcal serotypes
Hausdorff, W. P., Feikin, D. R., & Klugman, K. P. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)01280-6 · Cited by 606
Robbins, J. B., Austrian, R., Lee, C. J., Rastogi, S. C., Schiffman, G., Henrichsen, J., Makela, P. H., Broome, C. V., Facklam, R. R., Tiesjema, R. H., et al. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/148.6.1136 · Cited by 564
Maintaining protection against invasive bacteria with protein–polysaccharide conjugate vaccines
Pollard, A. J., Perrett, K. P., & Beverley, P. C. (2009) · Nature Reviews Immunology · doi:10.1038/nri2494 · Cited by 485
Dagan, R., Melamed, R., Muallem, M., Piglansky, L., Greenberg, D., Abramson, O., Mendelman, P. M., Bohidar, N., & Yagupsky, P. (1996) · Journal of Infectious Diseases · doi:10.1093/infdis/174.6.1271 · Cited by 477
Briles, D. E., Nahm, M., Schroer, K., Davie, J., Baker, P., Kearney, J., & Barletta, R. (1981) · The Journal of experimental medicine · doi:10.1084/jem.153.3.694 · Cited by 464
Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice
Zhang, Z., Clarke, T. B., & Weiser, J. N. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36731 · Cited by 456
Efficacy of pneumococcal vaccination in adults: a meta-analysis
Huss, A., Scott, P., Stuck, A. E., Trotter, C., & Egger, M. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.080734 · Cited by 414
Efficacy of Pneumococcal Vaccine in High-Risk Patients
Simberkoff, M. S., Cross, A. P., Al-Ibrahim, M., Baltch, A. L., Geiseler, P. J., Nadler, J., Richmond, A. S., Smith, R. P., Schiffman, G., Shepard, D. S., et al. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611203152104 · Cited by 395
Meningococcal Disease: Still with Us
Peltola, H. (1983) · Clinical Infectious Diseases · doi:10.1093/clinids/5.1.71 · Cited by 394
Vaccines for preventing pneumococcal infection in adults
Moberley, S., Holden, J., Tatham, D. P., & Andrews, R. M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000422.pub2 · Cited by 387
Robbins, J. B., Schneerson, R., & Szu, S. C. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/171.6.1387 · Cited by 385
Antibody Response to Pneumococcal Vaccination in Children Younger than Five Years of Age
Douglas, R. M., Paton, J. C., Duncan, S. J., & Hansman, D. J. (1983) · Journal of Infectious Diseases · doi:10.1093/infdis/148.1.131 · Cited by 377
Efficacy of Pneumococcal Vaccination in Adults: A Meta-analysis of Randomized Controlled Trials
Fine, M. J. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420230051007 · Cited by 370
Protective Efficacy of Pneumococcal Polysaccharide Vaccines
Smit, P. (1977) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1977.03280250039019 · Cited by 350
Peltola, H., Mäkelä, P. H., Käyhty, H., Jousimies, H., Herva, E., Hällström, K., Sivonen, A., Renkonen, O.-V., Pettay, O., Karanko, V., et al. (1977) · New England Journal of Medicine · doi:10.1056/nejm197709292971302 · Cited by 344
Broome, C. V., Facklam, R. R., & Fraser, D. W. (1980) · New England Journal of Medicine · doi:10.1056/nejm198009043031003 · Cited by 338
Pneumococcal Disease during HIV Infection: Epidemiologic, Clinical, and Immunologic Perspectives
Janoff, E. N., Breiman, R. F., Daley, C. L., & Hopewell, P. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-314 · Cited by 323
Immunology of bacterial polysaccharide antigens
Weintraub, A. (2003) · Carbohydrate Research · doi:10.1016/j.carres.2003.07.008 · Cited by 310
Yother, J. (2011) · Annual Review of Microbiology · doi:10.1146/annurev.micro.62.081307.162944 · Cited by 307
Nichol, K. L., Baken, L., Wuorenma, J., & Nelson, A. (1999) · Archives of Internal Medicine · doi:10.1001/archinte.159.20.2437 · Cited by 297
Mehta, R. H. (2009) · JAMA · doi:10.1001/jama.2009.600 · Cited by 293
Pathogenesis of Staphylococcus aureus Bloodstream Infections
Thomer, L., Schneewind, O., & Missiakas, D. (2016) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012615-044351 · Cited by 292
Austrian, R. (1981) · Clinical Infectious Diseases · doi:10.1093/clinids/3.supplement_1.s1 · Cited by 292
Envelope Structures of Gram-Positive Bacteria
Rajagopal, M., & Walker, S. (2015) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2015_5021 · Cited by 292
Toward Automated Oligosaccharide Synthesis
Hsu, C., Hung, S., Wu, C., & Wong, C. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201100125 · Cited by 273
The Immune Response to Pneumococcal Proteins during Experimental Human Carriage
McCool, T. L., Cate, T. R., Moy, G., & Weiser, J. N. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011576 · Cited by 270
Nuorti, J. P., Butler, J. C., Crutcher, J. M., Guevara, R., Welch, D., Holder, P., & Elliott, J. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382601 · Cited by 270
Architects at the bacterial surface — sortases and the assembly of pili with isopeptide bonds
Hendrickx, A. P. A., Budzik, J. M., Oh, S.-Y., & Schneewind, O. (2011) · Nature Reviews Microbiology · doi:10.1038/nrmicro2520 · Cited by 264
Pneumococcal Polysaccharide Vaccine: Recommendation of the Immunization Practices Advisory Committee
(1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-96-2-203 · Cited by 262
Limited Role of Antibody in Clearance of Streptococcus pneumoniae in a Murine Model of Colonization
McCool, T. L., & Weiser, J. N. (2004) · Infection and Immunity · doi:10.1128/iai.72.10.5807-5813.2004 · Cited by 153
Metadata
- Authors
- MacLeod, C. M., Hodges, R. G., Heidelberger, M., & Bernhard, W. G.
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1945-12-01
- Volume
- 82
- Issue
- 6
- Pages
- 445-465
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W1973815343
- Cited by
- 518
- References
- 1
- FWCI
- 8.98
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.